The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells

International Journal of Oncology

Volumn 30, Issue 3, 2007, Pages 641-650

  Hansen, Nathan J ^a   Wylie, Rebecca C ^a   Phipps, Sharla M O ^a   Love, William K ^a   Andrews, Lucy G ^a   Tollefsbol, Trygve O ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

9 cis UAB30 retinoic acid; Breast cancer; Retinoids; Telomerase

Indexed keywords

DNA (CYTOSINE 5 ) METHYLTRANSFERASE 1; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; NAPHTHALENE DERIVATIVE; RETINOIC ACID; RETINOID; TELOMERASE; UAB 30; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CELL PROLIFERATION; DOSE RESPONSE; DOWN REGULATION; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; TIME; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FATTY ACIDS, UNSATURATED; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NAPHTHALENES; RETINOIDS; TELOMERASE; TIME FACTORS; TRETINOIN;

EID: 33947716827     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.30.3.641     Document Type: Article

References (50)

1. Kelland LR: Overcoming the immortality of tumor cells by telomere and telomerase based cancer therapeutics - current status and future prospects. Eur J Cancer 41: 971-979, 2005.
2. Gudas L: Retinoids and vertebrate development. J Biol Chem 269: 15399-15402, 1994.
3. Choi SH, Kang HK, Im EO, et al: Inhibition of cell growth and telomerase activity in breast cancer cells in vitro by retinoic acids. Int J Oncol 17: 971-976, 2000.
4. Pendino F, Flexor M, Delhommeau F, Bute D, Lanotte M and Segal-Bendirdjian E: Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Proc Natl Acad Sci USA 98: 6662-6667, 2001.
5. Dedieu S and Lefebvre P: Retinoids interfere with the AP1 signalling pathway in human breast cancer cells. Cell Signal 18: 889-898, 2006.
6. Xiao X, Sidorov IA, Gee J, Lempicki RA and Dimitrov DS: Retinoic acid-induced downmodulation of telomerase activity in human cancer cells. Exp Mol Pathol 79: 108-117, 2005.
7. Pendino F, Hillion J, Dudognon C, et al: Telomerase targeting by retinoids in cells from patients with myeloid leukemias of various subtypes, not only APL. Leukemia 20: 599-603, 2006.
8. Sussman F and De Lera AR: Ligand recognition by RAR and RXR receptors: binding and selectivity. J Med Chem 48: 6212-6219, 2005.
9. Zhou Q, Stetler-Stevenson M and Steeg PS: Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro. Oncogene 15: 107-115, 1997.
10. Sheikh MS, Shao ZM, Chen JC, Ondonez JV and Fontana JA: Retinoid modulation of c-myc and max gene expression in human breast carcinoma. Anticancer Res 13: 1387-1392, 1993.
11. Roman SD, Clarke CL, Hall RE, Alexander IE and Sutherland RL: Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res 52: 2236-2242, 1992.
12. Schneider SM, Offterdinger M, Huber H and Grunt TW: Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells. Cancer Res 60: 5479-5487, 2000.
13. Czeczuga-Semeniuk E, Wolczynski S, Dzieciol J, Dabrowska M, Anchim T and Tomaszewska I: 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7. Cell Mol Biol Lett 6: 925-939, 2001.
14. Paik J, Blaner WS, Sommer KM, Moe R and Swisshelm K: Retinoids, retinoic acid receptors, and breast cancer. Cancer Invest 21: 304-312, 2003.
15. Lin F, Xiao D, Kolluri SK and Zhang X: Unique anti-activator protein-1 activity of retinoic acid receptor beta. Cancer Res 60: 3271-3280, 2000.
16. Yang L, Tin-UC, Wu K and Brown P: Role of retinoid receptors in the prevention and treatment of breast cancer. J Mamm Gland Biol Neopl 4: 377-388, 1999.
17. Dietze EC, Caldwell LE, Marcom K, et al: Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300. Microsc Res Tech 59: 23-40, 2002.
18. Farias EF, Arapshian A, Bleiweiss IJ, Waxman S, Zelent A and Mira-y-Lopez R: Retinoic acid receptor α2 growth suppressor epigenetically silenced in MCF-7 human breast cancer cells. Cell Growth Differ 13: 335-341, 2002.
19. Lacroix M and Leclercq G: Relevance of breast cancer cell lines as models for breast tumors: an update. Breast Cancer Res Treat 83: 249-289, 2004.
20. Wu Q, Dawson MI, Zheng Y, et al: Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Mol Cell Biol 17: 6598-6608, 1997.
21. Toma S, Isnardi L, Rafo P, et al: RARα antagonist RA 41-5253 inhibits proliferation and induces apoptosis in breast-cancer cell lines. Int J Cancer 78: 86-94, 1998.
22. Vivat-Hannah V, Bourguet W, Gottardis M and Gronemeyer H: Separation of retinoid X receptor homo- and heterodimerization functions. Mol Cell Biol 23: 7678-7688, 2003.
23. Miller VA, Benedetti FM, Rigas JR, et al: Initial clinical trial of a selective retinoid X receptor ligand LGD1069. J Clin Oncol 15: 790-795, 1997.
24. Shen Q and Brown PH: Novel aspects for the prevention of breast cancer: targeting transcription factors and signal transduction pathways. J Mamm Gland Biol Neoplasia 8: 45-73, 2003.
25. Muccio DM, Brouillette WJ, Breitman TR, et al: Conformationally defined retinoic acid analogues: 4 potential new agents for promyelocytic and juvenile myelomonocytic leukemias. J Med Chem 41: 1679-1687, 1998.
26. Atigadda VR, Vines KK, Grubbs CJ, et al: Conformationally defined retinoic acid analogues. 5. Large-scale synthesis and mammary cancer chemopreventive activity for (2E,4E,6Z,8E)-8-(3′,4′-dihydro- 1′(2′H)-naphthalen-1′-ylidene)-3,7-dimethyl-2,4, 6-octatrienoic acid (9cUAB30). J Med Chem 46: 3766-3769, 2003.
27. Grubbs CJ, Hill DL, Bland KI, et al: 9cUAB30, an RXR specific retinoid, and/or tamoxifen in the prevention of methyl-nitrosourea-induced mammary cancers. Cancer Lett 201: 17-24, 2003.
28. Fitzgerald P, Chandratna RA, Heyman RA and Allegretto EA: Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Cancer Res 57: 2642-2650, 1997.
29. Wu S, Zhang D, Donigan A, Dawson MI, Soprano DR and Soprano KJ: Effects of conformationally restricted synthetic retinoids on ovarian tumor cell growth. J Cell Biochem 68: 378-388, 1998.
30. Pratt MA, Niu M and White D: Differential regulation of protein expression, growth and apoptosis by natural and synthetic retinoids. J Cell Biochem 90: 692-708, 2003.
31. Lopatina N, Haskell JF, Andrews LG, Poole JC, Saldanha S, Tollefsbol TO: Differential maintenance and de novo methylating activity by three DNA methyltransferases in aging and immortalized fibroblasts. J Cell Biochem 84: 324-334, 2002.
32. Casillas MA Jr, Lopatina N, Andrews LG and Tollefsbol TO: Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts. Mol Cell Biochem 252: 33-43, 2003.
33. Guilleret I, Yan P, Grange F, Braunschweig R, Bosman FT and Benhattar J: Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity. Int J Cancer 101: 335-341, 2002.
34. Liu L, Saldanha SN, Pate MS, Andrews LG and Tollefsbol TO: Epigenetic regulation of human telomerase reverse transcriptase promoter activity during cellular differentiation. Genes Chromosomes Cancer 41: 26-37, 2004. (Pubitemid 38988735)
35. Elmore LW, Rehder CW, Di X, et al: Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J Biol Chem 277: 35509-33515, 2002.
36. Dietze EC, Troch MM, Bowie ML, Yee L, Bean GR and Seewaldt VL: CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. Biochem Biophys Res Commun 302: 841-848, 2003. (Pubitemid 36294051)
37. Mizuno S, Chijiwa T, Okamura T, et al: Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 97: 1172-1179, 2001.
38. Casillas MA, Brotherton SL, Andrews G, Ruppert JM and Tollefsbol TO: Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements. Gene 316: 57-65, 2003.
39. Mittal A, Pate MS, Wylie RC, Tollefsbol TO and Katiyar SK: EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and inducing apoptosis. Int J Oncol 24: 703-710, 2004.
40. Altucci L and Gronemeyer H: The promise of retinoids to fight against cancer. Nat Rev Cancer 1: 181-193, 2001. (Pubitemid 33741893)
41. Eckhardt S: Recent progress in the development of anticancer agents. Curr Med Chem Anti-Cancer Agents 2: 419-439, 2002. (Pubitemid 34649883)
42. Ahmed A and Tollefsbol T: Telomeres and telomerase: basic science implications for aging. J Am Geriatr Soc 49: 1105-1109, 2001.
43. Guilleret I and Benhattar J: Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Exp Cell Res 289: 326-334, 2003.
44. Pendino F, Dudognon C, Delhommeau F, et al: Retinoic acid receptor α and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death. Oncogene 22: 9142-9150, 2003.
45. Cao Y, Li H, Mu F-T, Ebisui O, Funder JW and Liu J: Telomerase activation causes vascular smooth muscle cell proliferation in genetic hypertension. FASEB J 16: 96-98, 2001.
46. Saretzski G, Ludwig A, von Zglinicki T and Runnebaum IB: Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells. Cancer Gene Ther 8: 827-834, 2001.
47. Rubin M, Fenig E, Rosenauer A, et al: 9-cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. Cancer Res 54: 6549-6656, 1994.
48. Cong YS, Wright WE and Shay JW: Human telomerase and its regulation. Microbiol Mol Biol Rev 66: 407-425, 2002.
49. Emionite L, Galmozzi F, Grattarola M, Boccardo F, Vergani L and Toma S: Histone deacetylase inhibitors enhance retinoid response in human breast cancer cell lines. Anticancer Res 24: 4019-4024, 2004.
50. Cao Y, Li H, Deb S and Liu J: TERT regulates cell survival independent of telomerase enzymatic activity. Oncogene 21: 3130-3138, 2002.